Clinical Trial: Dapagliflozin in the Treatment of Heart Failure
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Condition: Heart Failure
Study Type: Observational
Official Title: Safety and Efficacy of Dapagliflozin in the Treatment of Heart Failure in Non-diabetic Egyptian Patients
Brief Summary:
prospectively evaluation the safety and efficacy of the Sodium-glucose Cotransporter-2 (SGLT2) inhibitor dapagliflozin in non-diabetic patients with heart failure and a reduced ejection fraction
Read more